Skip to main content
SURGICAL INNOVATIONS GROUP PLC logo

SURGICAL INNOVATIONS GROUP PLC — Investor Relations & Filings

Ticker · SUN ISIN · GB0004016704 LEI · 2138004GHGUH3HUZE156 IL Manufacturing
Open in API
Filings indexed 277 across all filing types
Latest filing 2018-06-26 Earnings Release
Country GB United Kingdom
Listing IL SUN

About SURGICAL INNOVATIONS GROUP PLC

https://www.surgicalinnovations.com/

Surgical Innovations Group PLC designs, develops, manufactures, and distributes medical devices for minimally invasive surgery (MIS). The company specializes in creating sustainable and innovative solutions that aim to reduce the environmental impact of surgical procedures. A core part of its portfolio is the "Resposable®" technology, which integrates reusable and disposable components to offer clinically effective and environmentally conscious alternatives to single-use instruments. In addition to its branded products, the group provides original equipment manufacturing (OEM) services, engineering, and manufacturing for other medical device companies. The focus is on providing high-quality, accessible products for healthcare professionals performing keyhole surgery.

Recent filings

Filing Released Lang Actions
AGM Statement
Earnings Release Classification · 99% confidence The document is explicitly titled "AGM Statement" and states that the company "holds its Annual General Meeting at 3pm today." It contains a statement made by the Executive Chairman during this meeting, providing a business update and outlook. Although it mentions interim results will be released later, the primary content and context are directly related to the proceedings of the Annual General Meeting. This aligns perfectly with the definition for AGM Information (AGM-R). The presence of the RNS number confirms it is a regulatory announcement, but the specific content dictates the classification. H1 2018
2018-06-26 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled as an 'RNS Number' notification from 'Surgical Innovations Group PLC' dated June 4, 2018. The content is a 'TR-1: Standard form for notification of major holdings,' which details changes in voting rights and share ownership thresholds (crossing from 5.4411% to 4.9299%). This type of filing, reporting changes in significant shareholdings, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2018-06-04 English
Trading Update
Earnings Release Classification · 99% confidence The document begins with an 'RNS Number' and is dated May 25, 2018. It is titled 'Trading Update' and discusses current trading, revenue expectations, and profit outlook for the year ending December 31, 2018. It explicitly mentions that the information includes 'inside information as defined by Article 7 of the Market Abuse Regulation No. 596/2014' and is disclosed under Article 17. The document concludes by stating it is provided by 'RNS, the news service of the London Stock Exchange.' This structure strongly indicates a regulatory news service announcement. Since it is a trading update (a form of earnings/performance update) released via RNS, it is best classified as an Earnings Release (ER) if it contained the full results, or a general Regulatory Filing (RNS) if it's an interim update. Given the context of providing key performance indicators (revenue reduction estimate) and being disseminated via RNS, it functions as an early earnings/trading update. However, the primary mechanism of dissemination is the RNS system, and it is not a full quarterly report (IR) or a formal earnings release (ER) which usually contains detailed P&L. Since it is a general regulatory announcement disseminated through the RNS system that doesn't fit perfectly into ER or IR, RNS is the most appropriate fallback, although ER is a close second. Given the content is a 'Trading Update' which precedes the full results, ER is often used for these preliminary announcements. Let's re-evaluate the definitions. ER is 'Initial announcement of quarterly/periodical financial results (key highlights only).' This trading update fits that description well. RNS is the fallback. I will classify it as ER as it is a financial performance highlight announcement. FY 2018
2018-05-25 English
Group of companies' accounts made up to 2017-12-31
Regulatory Filings
2018-05-08 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is explicitly marked with 'RNS Number : 8159I' and contains detailed information regarding share purchases and sales by a Director/PDMR (Person Discharging Managerial Responsibilities) and their closely associated persons. This type of mandatory disclosure concerning insider transactions falls directly under the definition of Director's Dealing. The presence of the RNS header suggests it was released via the London Stock Exchange's Regulatory News Service, but the specific content dictates the classification should be DIRS, not the general RNS fallback.
2018-03-23 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is an official notification, indicated by the 'RNS Number' and the reference to the 'EU Market Abuse Regulation'. The content explicitly details share transactions (acquisition and sale) by a Director/PDMR (Executive Chairman, Nigel Rogers). This perfectly matches the definition of a Director's Dealing report, which corresponds to the code DIRS.
2018-03-13 English

Browse filings by year

36 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.